Publication Name	World Journal of Clinical Cases
Manuscript ID	83140
Country	China

Received	2023-10-26 03:19
Peer-Review Started	2023-10-26 03:19
To Make the First Decision
Return for Revision	2023-11-08 06:03
Revised	2023-11-22 09:03
Second Decision	2023-12-21 02:38
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-21 06:37
Articles in Press	2023-12-21 06:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-12-20 02:53
Typeset the Manuscript	2024-01-05 02:03
Publish the Manuscript Online	2024-01-11 05:28

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Integrative & Complementary Medicine
Manuscript Type	Meta-Analysis
Article Title	Efficacy and safety of Yangxue Qingnao Granules in treatment of migraine: A systematic review and meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Bo Zhou, Gui-Shu Wang, Yu-Ning Yao, Tong Hao, Huan-Qin Li and Ke-Gang Cao
ORCID	Author(s) ORCID Number Bo Zhou http://orcid.org/0000-0002-3232-5075 Ke-Gang Cao http://orcid.org/0000-0002-6285-2562
Funding Agency and Grant Number
Corresponding Author	Ke-Gang Cao, MD, Chief Physician, Institute for Brain Disorders, Beijing University of Chinese Medicine, No. 5, Dongzhimen, Dongcheng District, Beijing 100700, China. kgdoctor@sina.com
Key Words	Meta-analysis; Migraine; Yangxue Qingnao Granules; Traditional Chinese patent medicine
Core Tip	Traditional Chinese medicine is widely used as a treatment option for migraine. Clinical studies have confirmed the effectiveness of Yangxue Qingnao Granules (YXQN) for treatment of migraine. However, there is still insufficient evidence to evaluate the efficacy of YXQN for migraine. Therefore, this meta-analysis aimed to systematically integrate clinical trials to evaluate the efficacy and safety of YXQN alone in the treatment of migraine and provide a basis for its further clinical application and research.
Publish Date	2024-01-11 05:28
Citation	Zhou B, Wang GS, Yao YN, Hao T, Li HQ, Cao KG. Efficacy and safety of Yangxue Qingnao Granules in treatment of migraine: A systematic review and meta-analysis. World J Clin Cases 2023; 12(2): 335-345
URL	https://www.wjgnet.com/2307-8960/full/v12/i2/335.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i2.335

Full Article (PDF)	WJCC-12-335-with-cover.pdf
Full Article (Word)	WJCC-12-335.docx
PRISMA 2009 Checklist	83140-PRISMA 2009 checklist statement.pdf
Manuscript File	83140_Auto_Edited-CL-WangTQ-YJP.docx
Answering Reviewers	83140-Answering reviewers.pdf
Audio Core Tip	83140-Audio core tip.m4a
Biostatistics Review Certificate	83140-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	83140-Conflict-of-interest statement.pdf
Copyright License Agreement	83140-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	83140-Language certificate.pdf
Supplementary Material	83140-Supplementary material.pdf
Peer-review Report	83140-Peer-review(s).pdf
Scientific Misconduct Check	83140-Bing-Lin C-2.png
Scientific Editor Work List	83140-Scientific editor work list.pdf